Real-life asthma impairment: SABA use depends on smoking phenotype

被引：0

作者：

Martin, Richard ^{[7
,9
]}

Price, David ^{[8
,9
,10
]}

McIvor, Andrew ^{[2
,9
]}

Wong, Gary ^{[3
,9
]}

Krishnan, Jerry ^{[4
,9
]}

Campbell, Jonathan D. ^{[5
,9
]}

Bjermer, Leif ^{[6
,9
]}

Miravitlles, Marc ^{[1
,9
]}

Chisholm, Alison ^{[9
]}

Burden, Annie ^{[10
]}

机构：

[1] Hosp Univ Vall DHebron, Dept Pneumol, Barcelona, Spain

[2] McMaster Univ, Firestone Inst Resp Hlth, Hamilton, ON, Canada

[3] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China

[4] Univ Illinois, Med & Publ Hlth, Chicago, IL USA

[5] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Denver, CO 80202 USA

[6] Skane Univ Hosp, Resp Med & Allergol, Lund, Sweden

[7] Natl Jewish Hlth, Med, Denver, CO USA

[8] Univ Aberdeen, Primary Care Resp Med, Aberdeen, Scotland

[9] Resp Effectiveness Grp, Steering Grp, Cambridge, England

[10] Res Real Life Ltd, Stat & Hlth Outcomes, Cambridge, England

来源：

关键词：

Asthma; -; management; Primary care; Treatments;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2361

引用

页数：2